'Cadila Healthcare Shares' - 40 News Result(s)
- Business | Edited by Nikita Prasad | Friday August 20, 2021As part of the agreement, CHEMI will manufacture and supply the Enoxaparin Sodium injection which Zydus Cadila will commercialize in the United States
www.ndtv.com/business
- Business | Edited by Nikita Prasad | Wednesday August 11, 2021Cadila Healthcare's total revenue from operations in the first quarter of the current fiscal stood at Rs 4,025.4 crore, compared to Rs 3,514.6 crore in the year-ago period
www.ndtv.com/business
- Business | Edited by Nikita Prasad | Thursday May 27, 2021Zydus Cadila Q4 FY21 Results: Cadila Healthcare reported a 73 per cent rise in consolidated net profit to Rs 679 crore in the January-March quarter of the financial year 2020-21.
www.ndtv.com/business
- Business | Edited by Peter Noronha | Thursday February 25, 2021Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
www.ndtv.com/business
- Business | Edited by Peter Noronha | Monday December 28, 2020Reliance Industries shares may be on investors' radar after the conglomerate agreed to buy out IMG Worldwide LLC from their sports management joint venture for Rs 52.08 crore
www.ndtv.com/business
- Business | Written by Abhishek Vasudev | Tuesday April 21, 2020Zydus Cadila said that its biological therapy Pegylated Interferon alpha-2b, 'PegiHepTM' can emerge as one of the pathways to treat COVID 19.
www.ndtv.com/business
- Business | NDTV Profit Team | Wednesday October 24, 2018Stock markets closed higher on Wednesday, after four consecutive days of fall, as the rupee touched a three-week high amid falling crude oil prices. The Sensex rose 186 points to regain the 34,000 mark, which it had lost for the first time in past six months the previous day. NSE benchmark index Nifty settled 77 points higher at 10,224. Gains in fi...
www.ndtv.com/business
- Business | NDTV Profit Team | Monday November 20, 2017Cadila Healthcare shares trade (at 11.55 am) at Rs 450.50, 0.93% higher than the previous session's closing on BSE
www.ndtv.com/business
- Business | Press Trust of India | Wednesday August 30, 2017The company has more than 140 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.
www.ndtv.com/business
- Business | Ari Altstedter, Bloomberg | Thursday August 10, 2017Cadila's stock delivered returns of almost 50 percent, making it the best among generic drugmakers worldwide with a market value of more than $1 billion.
www.ndtv.com/business
- Business | Press Trust of India | Tuesday July 4, 2017The company has received tentative approval to market sitagliptin and metformin hydrochloride.
www.ndtv.com/business
- Business | NDTV Profit Team | Monday June 5, 2017HDFC Securities says the Nifty Pharma sub-index of NSE could bounce back up to 9600-9700 levels in next 2-3 months compared to its current value of 9,250.
www.ndtv.com/business
- Business | Written by Abhishek Vasudev | Tuesday May 23, 2017Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
www.ndtv.com/business
- Business | Press Trust of India | Friday February 17, 2017At NSE, shares of the company gained 7.27 per cent to touch a one-year high of Rs 460.75.
www.ndtv.com/business
- Business | Edited by Abhishek Vasudev | Thursday February 16, 2017Shares of drug maker Cadila Healthcare staged a swift rally (surging 18.4 per cent to hit high of Rs 424) and came in high demand in afternoon deals.
www.ndtv.com/business
'Cadila Healthcare Shares' - 1 Video Result(s)
'Cadila Healthcare Shares' - 40 News Result(s)
- Business | Edited by Nikita Prasad | Friday August 20, 2021As part of the agreement, CHEMI will manufacture and supply the Enoxaparin Sodium injection which Zydus Cadila will commercialize in the United States
www.ndtv.com/business
- Business | Edited by Nikita Prasad | Wednesday August 11, 2021Cadila Healthcare's total revenue from operations in the first quarter of the current fiscal stood at Rs 4,025.4 crore, compared to Rs 3,514.6 crore in the year-ago period
www.ndtv.com/business
- Business | Edited by Nikita Prasad | Thursday May 27, 2021Zydus Cadila Q4 FY21 Results: Cadila Healthcare reported a 73 per cent rise in consolidated net profit to Rs 679 crore in the January-March quarter of the financial year 2020-21.
www.ndtv.com/business
- Business | Edited by Peter Noronha | Thursday February 25, 2021Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
www.ndtv.com/business
- Business | Edited by Peter Noronha | Monday December 28, 2020Reliance Industries shares may be on investors' radar after the conglomerate agreed to buy out IMG Worldwide LLC from their sports management joint venture for Rs 52.08 crore
www.ndtv.com/business
- Business | Written by Abhishek Vasudev | Tuesday April 21, 2020Zydus Cadila said that its biological therapy Pegylated Interferon alpha-2b, 'PegiHepTM' can emerge as one of the pathways to treat COVID 19.
www.ndtv.com/business
- Business | NDTV Profit Team | Wednesday October 24, 2018Stock markets closed higher on Wednesday, after four consecutive days of fall, as the rupee touched a three-week high amid falling crude oil prices. The Sensex rose 186 points to regain the 34,000 mark, which it had lost for the first time in past six months the previous day. NSE benchmark index Nifty settled 77 points higher at 10,224. Gains in fi...
www.ndtv.com/business
- Business | NDTV Profit Team | Monday November 20, 2017Cadila Healthcare shares trade (at 11.55 am) at Rs 450.50, 0.93% higher than the previous session's closing on BSE
www.ndtv.com/business
- Business | Press Trust of India | Wednesday August 30, 2017The company has more than 140 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.
www.ndtv.com/business
- Business | Ari Altstedter, Bloomberg | Thursday August 10, 2017Cadila's stock delivered returns of almost 50 percent, making it the best among generic drugmakers worldwide with a market value of more than $1 billion.
www.ndtv.com/business
- Business | Press Trust of India | Tuesday July 4, 2017The company has received tentative approval to market sitagliptin and metformin hydrochloride.
www.ndtv.com/business
- Business | NDTV Profit Team | Monday June 5, 2017HDFC Securities says the Nifty Pharma sub-index of NSE could bounce back up to 9600-9700 levels in next 2-3 months compared to its current value of 9,250.
www.ndtv.com/business
- Business | Written by Abhishek Vasudev | Tuesday May 23, 2017Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
www.ndtv.com/business
- Business | Press Trust of India | Friday February 17, 2017At NSE, shares of the company gained 7.27 per cent to touch a one-year high of Rs 460.75.
www.ndtv.com/business
- Business | Edited by Abhishek Vasudev | Thursday February 16, 2017Shares of drug maker Cadila Healthcare staged a swift rally (surging 18.4 per cent to hit high of Rs 424) and came in high demand in afternoon deals.
www.ndtv.com/business